» Articles » PMID: 7806391

Analysis of Immunization Route-related Variation in the Immune Response to Heat-killed Salmonella Typhimurium in Mice

Overview
Journal Infect Immun
Date 1995 Jan 1
PMID 7806391
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In examinations of the factors regulating the quality and quantity of the immune response to Salmonella typhimurium, we have shown previously that live and heat-killed preparations of S. typhimurium can induce gamma interferon-dominant and interleukin-4-dominant immune responses, respectively, upon intraperitoneal (i.p.) immunization of BALB/c mice. Using this system to investigate the role of the route of immunization in the immune response, we show in the present study that i.p. immunization with heat-killed S. typhimurium generates a quantitatively better immune response than does intradermal (i.d.) immunization. The quantitative differences observed between the i.p. and i.d. routes are apparent in the amount of S. typhimurium-specific antibodies produced, the extent of responses in T-cell proliferation assays, and the quantities of lymphokines generated. However, the ratios of immunoglobulin (Ig) isotypes [IgG1/IgG2a] are comparable and the relative dominance of interleukin-4 over gamma interferon is seen in both i.p.- and i.d.-immunized mice, suggesting that the predominant T-cell effector pathways triggered are not qualitatively dependent on the route of immunization. An examination of the antigenic profile recognised by the B-cell and T-cell responses in i.p.- versus i.d.-immunized mice shows that while the Western immunoblot patterns recognized by serum antibodies from the two groups of mice were not significantly different, T cells from i.p.-immunized mice recognized a broader spectrum of antigens in an immunoblot assay than did those from i.d.-immunized mice. These data suggest that there may be a significant difference in the antigen-processing ability of peritoneal and dermal antigen-presenting cells for complex antigenic formulations such as bacterial vaccines.

Citing Articles

Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses.

Savoji M, Haghighat S, Mirzaee M, Golkaran B, Mirzaee R, Esfandiari B Gastroenterol Hepatol Bed Bench. 2019; 12(4):292-300.

PMID: 31749917 PMC: 6820835.


Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.

Mani R, Gupta M, Malik A, Tandon R, Prasad R, Bhatnagar R Infect Immun. 2018; 86(10).

PMID: 30104212 PMC: 6204737. DOI: 10.1128/IAI.00537-18.


Induction of IFN-γ cytokine response against hepatitis B surface antigen using melittin.

Dezfuli H, Shahbazzadeh D, Eidi A, Pooshang Bagheri K, Pakravan N, Amini S Gastroenterol Hepatol Bed Bench. 2014; 7(2):108-17.

PMID: 24834302 PMC: 4017562.


Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Ribeiro-Gomes F, Roma E, Carneiro M, Doria N, Sacks D, Peters N Infect Immun. 2014; 82(7):2713-27.

PMID: 24733090 PMC: 4097609. DOI: 10.1128/IAI.01600-13.


Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.

Pati N, Vishwakarma V, Selvaraj S, Dash S, Saha B, Singh N BMC Microbiol. 2013; 13:236.

PMID: 24148706 PMC: 3819739. DOI: 10.1186/1471-2180-13-236.


References
1.
Young D, Lamb J . T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology. 1986; 59(2):167-71. PMC: 1453182. View

2.
Brown A, Hormaeche C, Demarco de Hormaeche R, Winther M, Dougan G, Maskell D . An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned beta-galactosidase in mice. J Infect Dis. 1987; 155(1):86-92. DOI: 10.1093/infdis/155.1.86. View

3.
Snapper C, Paul W . Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987; 236(4804):944-7. DOI: 10.1126/science.3107127. View

4.
Sadoff J, Ballou W, Baron L, Majarian W, Brey R, Hockmeyer W . Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science. 1988; 240(4850):336-8. DOI: 10.1126/science.3281260. View

5.
Poirier T, Kehoe M, Beachey E . Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med. 1988; 168(1):25-32. PMC: 2188956. DOI: 10.1084/jem.168.1.25. View